The Prudential Financial Inc. Has $2,786,000 Position in First Commonwealth Financial Corporation (FCF)

The Prudential Financial Inc. Has $2,786,000 Position in First Commonwealth Financial Corporation (FCF)

Prudential Financial Inc. raised its position in shares of First Commonwealth Financial Corporation (NYSE:FCF) by 9.0% during the third quarter, Holdings Channel reports. The institutional investor owned 276,063 shares of the company’s stock after buying an additional 22,850 shares during the period. Prudential Financial Inc. owned approximately 0.31% of First Commonwealth Financial Corporation worth $2,786,000 at the end of the most recent reporting period. A number of other large investors have also made changes to their positions in the stock. BlackRock Fund Advisors raised its stake in shares of First…

The Verisk Analytics, Inc. (VRSK) Position Cut by Mitsubishi UFJ Kokusai Asset Management Co. Ltd.

The Verisk Analytics, Inc. (VRSK) Position Cut by Mitsubishi UFJ Kokusai Asset Management Co. Ltd.

Mitsubishi UFJ Kokusai Asset Management Co. Ltd. lowered its position in shares of Verisk Analytics, Inc. (NASDAQ:VRSK) by 15.8% during the third quarter, Holdings Channel reports. The fund owned 34,508 shares of the company’s stock after selling 6,483 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in Verisk Analytics were worth $2,805,000 at the end of the most recent quarter. Other institutional investors have also bought and sold shares of the company. Pinkerton Retirement Specialists LLC acquired a new position in Verisk Analytics during the second…

The Fragasso Group Inc. Has $2,823,000 Stake in Johnson & Johnson (JNJ)

The Fragasso Group Inc. Has $2,823,000 Stake in Johnson & Johnson (JNJ)

Fragasso Group Inc. reduced its position in Johnson & Johnson (NYSE:JNJ) by 2.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 23,902 shares of the company’s stock after selling 483 shares during the period. Johnson & Johnson comprises about 1.0% of Fragasso Group Inc.’s holdings, making the stock its 10th largest position. Fragasso Group Inc.’s holdings in Johnson & Johnson were worth $2,823,000 as of its most recent filing with the SEC. A number of other hedge funds have…

The BB&T Corporation (BBT) Stake Increased by DnB Asset Management AS

The BB&T Corporation (BBT) Stake Increased by DnB Asset Management AS

DnB Asset Management AS boosted its position in BB&T Corporation (NYSE:BBT) by 9.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 74,974 shares of the company’s stock after buying an additional 6,500 shares during the period. DnB Asset Management AS’s holdings in BB&T Corporation were worth $2,828,000 as of its most recent SEC filing. A number of other institutional investors have also recently modified their holdings of the company. WFG Advisors LP increased its position in BB&T Corporation…

The KeyCorp Comments on SM Energy Company’s Q1 2018 Earnings (SM)

The KeyCorp Comments on SM Energy Company’s Q1 2018 Earnings (SM)

SM Energy Company (NYSE:SM) – Equities research analysts at KeyCorp lifted their Q1 2018 earnings per share estimates for shares of SM Energy Company in a report released on Tuesday. KeyCorp analyst C. Stevens now anticipates that the firm will earn $0.31 per share for the quarter, up from their prior forecast of $0.25. KeyCorp also issued estimates for SM Energy Company’s Q2 2018 earnings at $0.28 EPS, Q3 2018 earnings at $0.51 EPS, Q4 2018 earnings at $0.87 EPS and FY2018 earnings at $1.98 EPS. Several other brokerages have…

The Neurocrine Biosciences, Inc. (NBIX) Receives Consensus Recommendation of “Buy” from Analysts

The Neurocrine Biosciences, Inc. (NBIX) Receives Consensus Recommendation of “Buy” from Analysts

Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) have earned an average rating of “Buy” from the fourteen research firms that are currently covering the firm. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and ten have issued a buy rating on the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $66.09. A number of research firms have commented on NBIX. Robert W. Baird reaffirmed a “buy” rating and set…

The Brunswick Corporation (BC) Given Consensus Rating of “Buy” by Brokerages

The Brunswick Corporation (BC) Given Consensus Rating of “Buy” by Brokerages

Shares of Brunswick Corporation (NYSE:BC) have been assigned an average rating of “Buy” from the eighteen analysts that are presently covering the firm. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and fourteen have assigned a buy rating to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $60.09. A number of analysts have recently commented on BC shares. Imperial Capital started coverage on Brunswick Corporation in a…

The PPG Industries, Inc. (PPG) Given Consensus Recommendation of “Hold” by Brokerages

The PPG Industries, Inc. (PPG) Given Consensus Recommendation of “Hold” by Brokerages

PPG Industries, Inc. (NYSE:PPG) has earned an average recommendation of “Hold” from the sixteen analysts that are covering the firm. Nine research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $111.89. Several equities analysts have recently weighed in on the stock. Citigroup Inc. lowered shares of PPG Industries from a “buy” rating to a “neutral” rating in a research…

The Seres Therapeutics, Inc. (MCRB) Given a $16.00 Price Target by Cantor Fitzgerald Analysts

The Seres Therapeutics, Inc. (MCRB) Given a $16.00 Price Target by Cantor Fitzgerald Analysts

Cantor Fitzgerald set a $16.00 price target on Seres Therapeutics, Inc. (NASDAQ:MCRB) in a research note released on Wednesday morning. The firm currently has a buy rating on the stock. Separately, Zacks Investment Research lowered Seres Therapeutics from a hold rating to a sell rating in a report on Wednesday, October 12th. One research analyst has rated the stock with a sell rating, one has given a hold rating and seven have assigned a buy rating to the stock. The stock has an average rating of Buy and an average…

The Regeneron Pharmaceuticals, Inc. (REGN) Given “Market Perform” Rating at Cowen and Company

The Regeneron Pharmaceuticals, Inc. (REGN) Given “Market Perform” Rating at Cowen and Company

Cowen and Company reiterated their market perform rating on shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) in a report issued on Wednesday. The firm currently has a $380.00 price objective on the biopharmaceutical company’s stock, down from their previous price objective of $400.00. REGN has been the subject of a number of other research reports. Leerink Swann set a $513.00 price target on shares of Regeneron Pharmaceuticals and gave the stock a buy rating in a research note on Tuesday, October 25th. Roth Capital reiterated a buy rating and issued a…

The LATAM Airlines Group S.A. (LFL) Coverage Initiated by Analysts at J P Morgan Chase & Co

The LATAM Airlines Group S.A. (LFL) Coverage Initiated by Analysts at J P Morgan Chase & Co

J P Morgan Chase & Co began coverage on shares of LATAM Airlines Group S.A. (NYSE:LFL) in a report released on Wednesday. The brokerage issued a hold rating and a $10.00 price target on the stock. A number of other research analysts have also commented on LFL. Citigroup Inc. upgraded shares of LATAM Airlines Group to a market perform rating in a research note on Wednesday, September 21st. Zacks Investment Research upgraded shares of LATAM Airlines Group from a hold rating to a buy rating and set a $9.25 price…

The Aqua America, Inc. (WTR) Downgraded to “Hold” at Zacks Investment Research

The Aqua America, Inc. (WTR) Downgraded to “Hold” at Zacks Investment Research

Zacks Investment Research lowered shares of Aqua America, Inc. (NYSE:WTR) from a buy rating to a hold rating in a research note released on Wednesday morning. According to Zacks, “Aqua America’s growth was primarily driven by higher contributions from the Regulated business and prudent expense management. Aqua America’s extensive network of water and wastewater systems, and continuous investments in regulated assets will help it to provide high-quality, reliable water services to its expanding customer base. However, the current rate of return from the company’s shares was lower than that of…

The CalAtlantic Group, Inc. (CAA) Receives “Buy” Rating from MKM Partners

The CalAtlantic Group, Inc. (CAA) Receives “Buy” Rating from MKM Partners

MKM Partners reaffirmed their buy rating on shares of CalAtlantic Group, Inc. (NYSE:CAA) in a research note issued to investors on Wednesday morning. A number of other brokerages have also recently commented on CAA. Barclays PLC began coverage on CalAtlantic Group in a research report on Thursday, January 5th. They issued an underweight rating and a $34.00 price target on the stock. Zacks Investment Research raised CalAtlantic Group from a sell rating to a hold rating in a research report on Tuesday, November 29th. FBR & Co reaffirmed a marketperform…

The Sumitomo Mitsui Financial Group Inc (SMFG) Shares Bought by World Asset Management Inc

The Sumitomo Mitsui Financial Group Inc (SMFG) Shares Bought by World Asset Management Inc

World Asset Management Inc raised its stake in Sumitomo Mitsui Financial Group Inc (NYSE:SMFG) by 8.1% during the third quarter, Holdings Channel reports. The institutional investor owned 472,931 shares of the company’s stock after buying an additional 35,313 shares during the period. World Asset Management Inc’s holdings in Sumitomo Mitsui Financial Group were worth $3,192,000 as of its most recent SEC filing. Several other institutional investors have also bought and sold shares of SMFG. Buckingham Asset Management LLC purchased a new position in Sumitomo Mitsui Financial Group during the third…

The Teva Pharmaceutical Industries Limited (TEVA) Stake Boosted by World Asset Management Inc

The Teva Pharmaceutical Industries Limited (TEVA) Stake Boosted by World Asset Management Inc

World Asset Management Inc boosted its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA) by 7.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 67,811 shares of the company’s stock after buying an additional 4,596 shares during the period. World Asset Management Inc’s holdings in Teva Pharmaceutical Industries Limited were worth $3,120,000 at the end of the most recent reporting period. Other institutional investors have also recently bought and sold shares of the company. Sharkey Howes…

The Karpas Strategies LLC Continues to Hold Stake in ONEOK Partners, L.P. (OKS)

The Karpas Strategies LLC Continues to Hold Stake in ONEOK Partners, L.P. (OKS)

Karpas Strategies LLC maintained its position in shares of ONEOK Partners, L.P. (NYSE:OKS) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 81,650 shares of the company’s stock at the end of the third quarter. ONEOK Partners, L.P. comprises about 1.6% of Karpas Strategies LLC’s investment portfolio, making the stock its 21st largest position. Karpas Strategies LLC’s holdings in ONEOK Partners, L.P. were worth $3,262,000 at the end of the most recent reporting period. Several other institutional investors also…

The Campbell Newman Asset Management Inc. Decreases Position in General Electric Company (GE)

The Campbell Newman Asset Management Inc. Decreases Position in General Electric Company (GE)

Campbell Newman Asset Management Inc. reduced its stake in shares of General Electric Company (NYSE:GE) by 4.2% during the third quarter, Holdings Channel reports. The institutional investor owned 111,431 shares of the company’s stock after selling 4,878 shares during the period. Campbell Newman Asset Management Inc.’s holdings in General Electric Company were worth $3,301,000 as of its most recent filing with the SEC. A number of other institutional investors have also recently added to or reduced their stakes in GE. Cable Hill Partners LLC increased its position in shares of…

The Willis Towers Watson Public Limited Company (WLTW) Upgraded by Zacks Investment Research to “Buy”

The Willis Towers Watson Public Limited Company (WLTW) Upgraded by Zacks Investment Research to “Buy”

Zacks Investment Research upgraded shares of Willis Towers Watson Public Limited Company (NASDAQ:WLTW) from a hold rating to a buy rating in a report issued on Wednesday. They currently have $141.00 price target on the stock. According to Zacks, “Shares of Willis Towers have gained 3.96% over the last one month, outperforming the Zacks categorized Brokers industry’s growth of 0.96%. Willis Towers is set to deliver $4.7 billion in long-term shareholder value via incremental revenue growth, cost synergies, and tax efficiencies besides unlocking balance sheet capacity. Going ahead, focus on…

The Willdan Group, Inc. (WLDN) Downgraded by Zacks Investment Research to “Sell”

The Willdan Group, Inc. (WLDN) Downgraded by Zacks Investment Research to “Sell”

Zacks Investment Research downgraded shares of Willdan Group, Inc. (NASDAQ:WLDN) from a buy rating to a sell rating in a report released on Wednesday morning. According to Zacks, “Willdan Group is a provider of professional technical and consulting services to utilities, private industry, and public agencies at all levels of government. Nationwide, they enable their clients to realize cost and energy savings by providing a wide range of specialized services. They assist their clients with a broad range of complementary services relating to: Energy Efficiency and Sustainability; Engineering and Planning;…

The FY2018 EPS Estimates for MUELLER WATER PRODUCTS (MWA) Reduced by Gabelli

The FY2018 EPS Estimates for MUELLER WATER PRODUCTS (MWA) Reduced by Gabelli

MUELLER WATER PRODUCTS (NYSE:MWA) – Investment analysts at Gabelli decreased their FY2018 EPS estimates for MUELLER WATER PRODUCTS in a research note issued to investors on Tuesday. Gabelli analyst J. Garza now forecasts that the brokerage will earn $0.60 per share for the year, down from their prior estimate of $0.70. MWA has been the subject of a number of other reports. Oppenheimer Holdings, Inc. reiterated an “outperform” rating and set a $15.00 target price (up from $13.00) on shares of MUELLER WATER PRODUCTS in a research report on Monday,…